Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigil Haroon

Showing results (21-30 of 149) with videos related to

Pageof 15
Sort By:
Nature Reviews. Rheumatology|June 10, 2010
Endoplasmic reticulum aminopeptidases: Biology and pathogenic potentialNigil Haroon, Robert D Inman
Bulletin of the NYU Hospital for Joint Diseases|October 26, 2010
Ankylosing spondylitis - new criteria, new treatmentsNigil Haroon, Robert D Inman
Current Opinion in Rheumatology|May 5, 2009
Infectious complications of biological therapyNigil Haroon, Robert D Inman
Best Practice & Research. Clinical Rheumatology|December 5, 2018
Evolving concepts of new bone formation in axial spondyloarthritis: Insights from animal models and human studiesRik J Lories, Nigil Haroon
Endocrinology and Metabolism Clinics of North America|July 26, 2023
Management of Metabolic-Associated Fatty Liver DiseaseKirthika Venkatesan, Nisha Nigil Haroon
Seminars in Immunopathology|March 25, 2021
Recent advances in spondyloarthritis: positive developments in the seronegative domainNigil Haroon, Robert D Inman
Best Practice & Research. Clinical Rheumatology|December 10, 2014
Bone formation in axial spondyloarthritisRik J Lories, Nigil Haroon
Nature Reviews. Rheumatology|February 1, 2023
ERAP1 and the return of the UPR in ankylosing spondylitisNigil Haroon, Robert D Inman
Arthritis & Rheumatology (Hoboken, N.J.)|May 11, 2026
T cells, the next big target in axSpA?Mansi K Aparnathi, Nigil Haroon
Modern Rheumatology|December 17, 2021
Complexity of enthesitis and new bone formation in ankylosing spondylitis: current understanding of the immunopathology and therapeutic approachesMasaki Kusuda, Nigil Haroon, Akihiro Nakamura
Pageof 15

Showing results (21-30 of 149) with videos related to

Sort By:
Pageof 15
Nature Reviews. Rheumatology|June 10, 2010
Endoplasmic reticulum aminopeptidases: Biology and pathogenic potentialNigil Haroon, Robert D Inman
Bulletin of the NYU Hospital for Joint Diseases|October 26, 2010
Ankylosing spondylitis - new criteria, new treatmentsNigil Haroon, Robert D Inman
Current Opinion in Rheumatology|May 5, 2009
Infectious complications of biological therapyNigil Haroon, Robert D Inman
Best Practice & Research. Clinical Rheumatology|December 5, 2018
Evolving concepts of new bone formation in axial spondyloarthritis: Insights from animal models and human studiesRik J Lories, Nigil Haroon
Endocrinology and Metabolism Clinics of North America|July 26, 2023
Management of Metabolic-Associated Fatty Liver DiseaseKirthika Venkatesan, Nisha Nigil Haroon
Seminars in Immunopathology|March 25, 2021
Recent advances in spondyloarthritis: positive developments in the seronegative domainNigil Haroon, Robert D Inman
Best Practice & Research. Clinical Rheumatology|December 10, 2014
Bone formation in axial spondyloarthritisRik J Lories, Nigil Haroon
Nature Reviews. Rheumatology|February 1, 2023
ERAP1 and the return of the UPR in ankylosing spondylitisNigil Haroon, Robert D Inman
Arthritis & Rheumatology (Hoboken, N.J.)|May 11, 2026
T cells, the next big target in axSpA?Mansi K Aparnathi, Nigil Haroon
Modern Rheumatology|December 17, 2021
Complexity of enthesitis and new bone formation in ankylosing spondylitis: current understanding of the immunopathology and therapeutic approachesMasaki Kusuda, Nigil Haroon, Akihiro Nakamura
Pageof 15